Viewing StudyNCT00293332



Ignite Creation Date: 2024-05-05 @ 4:41 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00293332
Status: TERMINATED
Last Update Posted: 2011-02-09
First Post: 2006-02-16

Brief Title: Docetaxel Carboplatin and Bevacizumab in Treating Patients With Stage I Stage II or Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery
Sponsor:
Organization: University of California San Francisco